Actiste® Mini receives market approval in the Kingdom of Saudi Arabia
Brighter AB (publ) is proud to announce that the diabetes management device Actiste® Mini has received market approval from the Saudi Food and Drug Authority (SFDA). Actiste® Mini is a smart and user-friendly blood glucose meter with global out-of-the-box internet connectivity through eSIM, aiming to support successful diabetes management and monitoring. The new device, based on the original Actiste® hardware technology platform, will be a key component in a new service currently being developed by Brighter. In November 2020, Brighter announced that the company's first product,